Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kamil Drucis
Improved Overall Survival in Melanoma With Combined Dabrafenib and Trametinib
New England Journal of Medicine
Medicine
Related publications
Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma
Frontiers in Oncology
Cancer Research
Oncology
Combined Modality Therapy Results in Improved Overall Survival for Angiosarcoma
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Optimizing Combination Dabrafenib and Trametinib Therapy in BRAF Mutation-Positive Advanced Melanoma Patients: Guidelines From Australian Melanoma Medical Oncologists
Asia-Pacific Journal of Clinical Oncology
Medicine
Oncology
Ipilimumab, Vemurafenib, Dabrafenib, and Trametinib: Synergistic Competitors in the Clinical Management of BRAF Mutant Malignant Melanoma
Oncologist
Cancer Research
Medicine
Oncology
Verbessertes Gesamtüberleben Mit Der Kombination Dabrafenib Und Trametinib
hautnah
BRAF-mutant Transcriptional Subtypes Predict Outcome of Combined BRAF, MEK, and EGFR Blockade With Dabrafenib, Trametinib, and Panitumumab in Patients With Colorectal Cancer
Clinical Cancer Research
Cancer Research
Oncology
Granulomatosis With Polyangiitis in a Patient Treated With Dabrafenib and Trametinib for BRAF V600E Positive Lung Adenocarcinoma
BMC Cancer
Cancer Research
Oncology
Genetics
Potassium Iodide in Successful Treatment of Erythema Nodosum‐like Lesions Induced by Combination Therapy With Dabrafenib and Trametinib
Journal of Dermatology
Dermatology
Medicine
Combined Modality Therapy Improves Overall Survival for Angiosarcoma
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
